Bcel stock forecast.

Coterra Energy Inc () Stock Market info Recommendations: Buy or sell Coterra Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below.According to present data Coterra Energy's CTRA shares and potentially its market environment have …Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...Stocks & ETFs, MFs & FOREX. AI Trend Prediction Engine. Stocks & ETFs, MFs & FOREXThe U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...

$191.45 +1.76 +0.93% Find the latest analyst research for Atreca, Inc. Class A Common Stock (BCEL) at Nasdaq.com.The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This …Atreca, Inc. - Hold. Zacks' proprietary data indicates that Atreca, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the BCEL shares relative to the market in ...

VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.11.30% of Atreca stock is owned by insiders. Which Atreca insiders have been selling company stock? The following insiders have sold BCEL shares in the last 24 months: Bros. Advisors Lp Baker ($109,895.60), John A Orwin ($37,216.24), Phillips Courtney ($15,321.16), and Tito Serafini ($199,122.53).The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...

Stock Target Advisor’s own stock analysis of Atreca Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Atreca Inc’s stock price was USD 0.22. Atreca Inc’s stock price has changed by -5.11% over the past week, +8.25% over the past month and -79.54% over the last year.

Average. $3.25. Current Price. $0.21. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...

The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ... Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ... May 10, 2023 · On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best Stocks See ENTHUSIAST GAMING HOLDINGS INC stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 1.93 0.00 0.00%. The 7 analysts offering 1 year price forecasts for EGLX have a max estimate of — and a min estimate of —.Find real-time VCEL - Vericel Corp stock quotes, company profile, news and forecasts from CNN Business.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.The 6 analysts offering 12-month price forecasts for Tecnoglass Inc have a median target of 50.00, with a high estimate of 56.00 and a low estimate of 45.00. The median estimate represents a +40. ...

Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ... Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Allakos Inc have a median target of 9.50, with a high estimate of 22.00 and a low estimate of 1.50. The median estimate ...Nov 6, 2023 · Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecasts Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ...Earnings vs Market: BCEL is forecast to remain unprofitable over the next 3 years. High Growth Earnings : BCEL is forecast to remain unprofitable over the next 3 …

12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...Coterra Energy Inc () Stock Market info Recommendations: Buy or sell Coterra Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below.According to present data Coterra Energy's CTRA shares and potentially its market environment have …

DM Stock 12 Months Forecast. $1.00. (27.88% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Desktop Metal in the last 3 months. The average price target is $1.00 with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 27.88% change from the last price of $0.78.Dec 2, 2023 · The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low. 11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts.BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share).Find real-time VCEL - Vericel Corp stock quotes, company profile, news and forecasts from CNN Business.ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Average. $3.25. Current Price. $0.21. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum. 12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...

Turning Spencer's outlook into concrete recommendations, Baird analyst Joel Beatty is pounding the table on two stocks that look especially compelling. According to the analyst, each name is ...

BCEL is currently rated as a Sucker Stock | Stockopedia. Login Get Started. Sectors Healthcare Biotechnology & Medical Research Atreca. ... Is there a Atreca share price forecast for 2023? The analyst consensus target price for shares in Atreca is $3.25. That is 1420.11% above the last closing price of $0.21.

See Atreca, Inc. (BCEL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. CRNT Earnings Forecast. Next quarter’s earnings estimate for CRNT is $0.06 with a range of $0.06 to $0.06. The previous quarter’s EPS was $0.06. CRNT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 66.36% of the time in the same period. In the last calendar year CRNT has ...Find real-time ALLK - Allakos Inc stock quotes, company profile, news and forecasts from CNN Business.Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.The current Cheniere Energy [ LNG] share price is $179.21. The Score for LNG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. LNG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...Zacks News for BCEL Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37% 08/14/23-9:51AM EST Zacks Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now 04/06/23-8:55AM EST ... Tecnoglass Inc. (NASDAQ:TGLS) released its earnings results on Monday, November, 6th. The company reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.97 by $0.01. The company earned $210.30 million during the quarter, compared to analysts' expectations of $206.25 million.

Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for …ALEC Stock 12 Months Forecast. $13.78. (169.14% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Alector in the last 3 months. The average price target is $13.78 with a high forecast of $41.00 and a low forecast of $4.00. The average price target represents a 169.14% change from the last price of $5.12.Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum.Instagram:https://instagram. iqcent brokerdrone insurance by the hourprivate wealth firmsroivant sciences stock The average Morphic Holding stock price prediction forecasts a potential upside of 124.84% from the current MORF share price of $23.72. What is MORF's forecast return on equity (ROE) for 2023-2025? (NASDAQ: MORF) forecast ROE is -29.51%, which is considered weak. 20 year treasury yieldtotal protect home warranty reviews BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$.. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%.During that period the price should oscillate between -9.61% and +7.63%.. In the medium term (3months), BCEL's …Atreca Inc (BCEL) Stock Price & News - Google Finance Home BCEL • NASDAQ Atreca Inc Follow Share $0.21 After Hours: $0.22 (2.90%) +0.0062 Closed: Nov 24, 3:00:17 PM GMT-5 · USD · NASDAQ ·... most fun us cities Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...